학술논문

Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase
Document Type
Article
Source
American Journal of Cardiology. Jan2004, Vol. 93 Issue 2, p195. 4p.
Subject
*FIBRINOLYSIS
*MYOCARDIAL infarction
*BLOOD coagulation
*BIOMARKERS
Language
ISSN
0002-9149
Abstract
Fibrinolysis in acute myocardial infarction activates blood coagulation and may favor reocclusion or ischemic complications. The aim of the GUSTO V Italian Hematologic Substudy was to compare the effects of full-dose reteplase on coagulation activation markers with those of half-dose reteplase combined with full-dose abciximab, a platelet glycoprotein IIb/IIIa receptor antagonist, during the early phase after acute myocardial infarction. [Copyright &y& Elsevier]